Day: May 21, 2026

Complete research guide to PT-141 (Bremelanotide) — the FDA-approved melanocortin receptor agonist. Covers CNS mechanism, RECONNECT Phase 3 trial data, melanocortin receptor profile, dosage reference, and where to buy for research.

Complete research guide to SLU-PP-332 — the ERR pan-agonist exercise mimetic compound. Covers ERRα/γ mechanism, 2023 Washington University endurance data, mitochondrial biogenesis, comparison with AICAR, and where to buy for research.

A comprehensive research guide to retatrutide peptide — the GLP-1/GIP/glucagon triple agonist. Covers mechanism, clinical trial data, dosage protocols, side effects, and research sourcing.